NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW

NEXGEL, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026

$5.80+0.21 (+3.76%)

Close on Oct 19, 2026

Market cap: $52.28M
P/E (TTM): –
Dividend yield: –

Dividends

Nexgel has not reported a dividend

No dividend per share appears in Nexgel's annual filings since fiscal 2017.

Where these numbers come from

Parsed from the XBRL in Nexgel's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Oct 12, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NXGL.

Revenue growth3.4% · median 22.4%

Gross margin35.1% · median 38.9%

Operating margin-44.8% · median -6.4%

Net margin-51.3% · median -9.9%

Company	Revenue	Growth
KRMD	$45.11M	+22.4%
RVP	$33.90M	-11.2%
SNOA	$21.92M	+47.0%
NEPH	$20.72M	+24.2%
SRTS	$17.51M	-53.4%
NXGL	$12.07M	+3.4%

Company

Next earnings (est.): Nov 11, 2026, before open
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 19
Auditor: Turner, Stone & Company, L.L.P.
SEC CIK: 1468929

Advertisement
300 × 250